 | • レポートコード：MRC2-11QY04165 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は爪囲炎治療のグローバル市場について調査・分析したレポートです。種類別（急性爪囲炎、慢性爪囲炎、カンジダ爪囲炎、化膿性爪囲炎）市場規模、用途別（ムピロシン軟膏、フシジン酸軟膏、ゲンタマイシン軟膏、ジクロキサシリン）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別爪囲炎治療の競争状況、市場シェア ・世界の爪囲炎治療市場：種類別市場規模 2015年-2020年（急性爪囲炎、慢性爪囲炎、カンジダ爪囲炎、化膿性爪囲炎） ・世界の爪囲炎治療市場：種類別市場規模予測 2021年-2026年（急性爪囲炎、慢性爪囲炎、カンジダ爪囲炎、化膿性爪囲炎） ・世界の爪囲炎治療市場：用途別市場規模 2015年-2020年（ムピロシン軟膏、フシジン酸軟膏、ゲンタマイシン軟膏、ジクロキサシリン） ・世界の爪囲炎治療市場：用途別市場規模予測 2021年-2026年（ムピロシン軟膏、フシジン酸軟膏、ゲンタマイシン軟膏、ジクロキサシリン） ・北米の爪囲炎治療市場分析：米国、カナダ ・ヨーロッパの爪囲炎治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの爪囲炎治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の爪囲炎治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの爪囲炎治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Glenmark Generics、Teva Pharmaceutical Industries、Eli Lilly、Jonakayem Pharma Formulation、Fougera Pharmaceuticals、Taro Pharmaceutical Industries ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Paronychia is a nail disease that is an often-tender bacterial or fungal infection of the hand or foot where the nail and skin meet at the side or the base of a finger or toenail. The infection can start suddenly (acute paronychia) or gradually (chronic paronychia).
When no pus is present, warm soaks for acute paronychia is reasonable, even though there is a lack of evidence to support its use. Antibiotics such as clindamycin or cephalexin are also often used, the first being more effective in areas where MRSA is common. If there are signs of an abscess (the presence of pus) drainage is recommended. Chronic paronychia is treated by avoiding whatever is causing it, a topical antifungal, and a topical steroid. In those who do not improve following these measures oral antifungals and steroids may be used or the nail fold may be removed surgically.
Market Analysis and Insights: Global Paronychia Treatment Market
The global Paronychia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Paronychia Treatment Scope and Market Size
Paronychia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Paronychia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GlaxoSmithKline
Glenmark Generics
Teva Pharmaceutical Industries
Eli Lilly
Jonakayem Pharma Formulation
Fougera Pharmaceuticals
Taro Pharmaceutical Industries
…
Market segment by Type, the product can be split into
Acute Paronychia
Chronic Paronychia
Candidal Paronychia
Pyogenic Paronychia
Market segment by Application, split into
Mupirocin Ointment
Fusidic Acid Ointment
Gentamicin Ointment
Dicloxacillin
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Paronychia Treatment Revenue
1.4 Market by Type
1.4.1 Global Paronychia Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Acute Paronychia
1.4.3 Chronic Paronychia
1.4.4 Candidal Paronychia
1.4.5 Pyogenic Paronychia
1.5 Market by Application
1.5.1 Global Paronychia Treatment Market Share by Application: 2020 VS 2026
1.5.2 Mupirocin Ointment
1.5.3 Fusidic Acid Ointment
1.5.4 Gentamicin Ointment
1.5.5 Dicloxacillin
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Paronychia Treatment Market Perspective (2015-2026)
2.2 Global Paronychia Treatment Growth Trends by Regions
2.2.1 Paronychia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Paronychia Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Paronychia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Paronychia Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Paronychia Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Paronychia Treatment Players by Market Size
3.1.1 Global Top Paronychia Treatment Players by Revenue (2015-2020)
3.1.2 Global Paronychia Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Paronychia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Paronychia Treatment Market Concentration Ratio
3.2.1 Global Paronychia Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Paronychia Treatment Revenue in 2019
3.3 Paronychia Treatment Key Players Head office and Area Served
3.4 Key Players Paronychia Treatment Product Solution and Service
3.5 Date of Enter into Paronychia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Paronychia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Paronychia Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Paronychia Treatment Market Size by Application (2015-2020)
5.2 Global Paronychia Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Paronychia Treatment Market Size (2015-2020)
6.2 Paronychia Treatment Key Players in North America (2019-2020)
6.3 North America Paronychia Treatment Market Size by Type (2015-2020)
6.4 North America Paronychia Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Paronychia Treatment Market Size (2015-2020)
7.2 Paronychia Treatment Key Players in Europe (2019-2020)
7.3 Europe Paronychia Treatment Market Size by Type (2015-2020)
7.4 Europe Paronychia Treatment Market Size by Application (2015-2020)
8 China
8.1 China Paronychia Treatment Market Size (2015-2020)
8.2 Paronychia Treatment Key Players in China (2019-2020)
8.3 China Paronychia Treatment Market Size by Type (2015-2020)
8.4 China Paronychia Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Paronychia Treatment Market Size (2015-2020)
9.2 Paronychia Treatment Key Players in Japan (2019-2020)
9.3 Japan Paronychia Treatment Market Size by Type (2015-2020)
9.4 Japan Paronychia Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Paronychia Treatment Market Size (2015-2020)
10.2 Paronychia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Paronychia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Paronychia Treatment Market Size by Application (2015-2020)
11 India
11.1 India Paronychia Treatment Market Size (2015-2020)
11.2 Paronychia Treatment Key Players in India (2019-2020)
11.3 India Paronychia Treatment Market Size by Type (2015-2020)
11.4 India Paronychia Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Paronychia Treatment Market Size (2015-2020)
12.2 Paronychia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Paronychia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Paronychia Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Paronychia Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Paronychia Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Glenmark Generics
13.2.1 Glenmark Generics Company Details
13.2.2 Glenmark Generics Business Overview
13.2.3 Glenmark Generics Paronychia Treatment Introduction
13.2.4 Glenmark Generics Revenue in Paronychia Treatment Business (2015-2020)
13.2.5 Glenmark Generics Recent Development
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Details
13.3.2 Teva Pharmaceutical Industries Business Overview
13.3.3 Teva Pharmaceutical Industries Paronychia Treatment Introduction
13.3.4 Teva Pharmaceutical Industries Revenue in Paronychia Treatment Business (2015-2020)
13.3.5 Teva Pharmaceutical Industries Recent Development
13.4 Eli Lilly
13.4.1 Eli Lilly Company Details
13.4.2 Eli Lilly Business Overview
13.4.3 Eli Lilly Paronychia Treatment Introduction
13.4.4 Eli Lilly Revenue in Paronychia Treatment Business (2015-2020)
13.4.5 Eli Lilly Recent Development
13.5 Jonakayem Pharma Formulation
13.5.1 Jonakayem Pharma Formulation Company Details
13.5.2 Jonakayem Pharma Formulation Business Overview
13.5.3 Jonakayem Pharma Formulation Paronychia Treatment Introduction
13.5.4 Jonakayem Pharma Formulation Revenue in Paronychia Treatment Business (2015-2020)
13.5.5 Jonakayem Pharma Formulation Recent Development
13.6 Fougera Pharmaceuticals
13.6.1 Fougera Pharmaceuticals Company Details
13.6.2 Fougera Pharmaceuticals Business Overview
13.6.3 Fougera Pharmaceuticals Paronychia Treatment Introduction
13.6.4 Fougera Pharmaceuticals Revenue in Paronychia Treatment Business (2015-2020)
13.6.5 Fougera Pharmaceuticals Recent Development
13.7 Taro Pharmaceutical Industries
13.7.1 Taro Pharmaceutical Industries Company Details
13.7.2 Taro Pharmaceutical Industries Business Overview
13.7.3 Taro Pharmaceutical Industries Paronychia Treatment Introduction
13.7.4 Taro Pharmaceutical Industries Revenue in Paronychia Treatment Business (2015-2020)
13.7.5 Taro Pharmaceutical Industries Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Paronychia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Paronychia Treatment Revenue
Table 3. Ranking of Global Top Paronychia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Paronychia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acute Paronychia
Table 6. Key Players of Chronic Paronychia
Table 7. Key Players of Candidal Paronychia
Table 8. Key Players of Pyogenic Paronychia
Table 9. Global Paronychia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Paronychia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Paronychia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Paronychia Treatment Market Share by Regions (2015-2020)
Table 13. Global Paronychia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Paronychia Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Paronychia Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Paronychia Treatment Players
Table 20. Global Paronychia Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Paronychia Treatment Market Share by Players (2015-2020)
Table 22. Global Top Paronychia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paronychia Treatment as of 2019)
Table 23. Global Paronychia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Paronychia Treatment Product Solution and Service
Table 26. Date of Enter into Paronychia Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Paronychia Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Paronychia Treatment Market Size Share by Type (2015-2020)
Table 30. Global Paronychia Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Paronychia Treatment Market Size Share by Application (2015-2020)
Table 32. Global Paronychia Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Paronychia Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Paronychia Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Paronychia Treatment Market Share (2019-2020)
Table 36. North America Paronychia Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Paronychia Treatment Market Share by Type (2015-2020)
Table 38. North America Paronychia Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Paronychia Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Paronychia Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Paronychia Treatment Market Share (2019-2020)
Table 42. Europe Paronychia Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Paronychia Treatment Market Share by Type (2015-2020)
Table 44. Europe Paronychia Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Paronychia Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Paronychia Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Paronychia Treatment Market Share (2019-2020)
Table 48. China Paronychia Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Paronychia Treatment Market Share by Type (2015-2020)
Table 50. China Paronychia Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Paronychia Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Paronychia Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Paronychia Treatment Market Share (2019-2020)
Table 54. Japan Paronychia Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Paronychia Treatment Market Share by Type (2015-2020)
Table 56. Japan Paronychia Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Paronychia Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Paronychia Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Paronychia Treatment Market Share (2019-2020)
Table 60. Southeast Asia Paronychia Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Paronychia Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Paronychia Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Paronychia Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Paronychia Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Paronychia Treatment Market Share (2019-2020)
Table 66. India Paronychia Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Paronychia Treatment Market Share by Type (2015-2020)
Table 68. India Paronychia Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Paronychia Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Paronychia Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Paronychia Treatment Market Share (2019-2020)
Table 72. Central & South America Paronychia Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Paronychia Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Paronychia Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Paronychia Treatment Market Share by Application (2015-2020)
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Revenue in Paronychia Treatment Business (2015-2020) (Million US$)
Table 80. GlaxoSmithKline Recent Development
Table 81. Glenmark Generics Company Details
Table 82. Glenmark Generics Business Overview
Table 83. Glenmark Generics Product
Table 84. Glenmark Generics Revenue in Paronychia Treatment Business (2015-2020) (Million US$)
Table 85. Glenmark Generics Recent Development
Table 86. Teva Pharmaceutical Industries Company Details
Table 87. Teva Pharmaceutical Industries Business Overview
Table 88. Teva Pharmaceutical Industries Product
Table 89. Teva Pharmaceutical Industries Revenue in Paronychia Treatment Business (2015-2020) (Million US$)
Table 90. Teva Pharmaceutical Industries Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Product
Table 94. Eli Lilly Revenue in Paronychia Treatment Business (2015-2020) (Million US$)
Table 95. Eli Lilly Recent Development
Table 96. Jonakayem Pharma Formulation Company Details
Table 97. Jonakayem Pharma Formulation Business Overview
Table 98. Jonakayem Pharma Formulation Product
Table 99. Jonakayem Pharma Formulation Revenue in Paronychia Treatment Business (2015-2020) (Million US$)
Table 100. Jonakayem Pharma Formulation Recent Development
Table 101. Fougera Pharmaceuticals Company Details
Table 102. Fougera Pharmaceuticals Business Overview
Table 103. Fougera Pharmaceuticals Product
Table 104. Fougera Pharmaceuticals Revenue in Paronychia Treatment Business (2015-2020) (Million US$)
Table 105. Fougera Pharmaceuticals Recent Development
Table 106. Taro Pharmaceutical Industries Company Details
Table 107. Taro Pharmaceutical Industries Business Overview
Table 108. Taro Pharmaceutical Industries Product
Table 109. Taro Pharmaceutical Industries Revenue in Paronychia Treatment Business (2015-2020) (Million US$)
Table 110. Taro Pharmaceutical Industries Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paronychia Treatment Market Share by Type: 2020 VS 2026
Figure 2. Acute Paronychia Features
Figure 3. Chronic Paronychia Features
Figure 4. Candidal Paronychia Features
Figure 5. Pyogenic Paronychia Features
Figure 6. Global Paronychia Treatment Market Share by Application: 2020 VS 2026
Figure 7. Mupirocin Ointment Case Studies
Figure 8. Fusidic Acid Ointment Case Studies
Figure 9. Gentamicin Ointment Case Studies
Figure 10. Dicloxacillin Case Studies
Figure 11. Paronychia Treatment Report Years Considered
Figure 12. Global Paronychia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Paronychia Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Paronychia Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Paronychia Treatment Market Share by Players in 2019
Figure 17. Global Top Paronychia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paronychia Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Paronychia Treatment Revenue in 2019
Figure 19. North America Paronychia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Paronychia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Paronychia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Paronychia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Paronychia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Paronychia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Paronychia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
爪囲炎治療薬の世界市場（～2026年） Paronychia usually happens when the skin around an individual's nail is irritated or harmed. Paronychia is a soft tissue infection of the skin around the fingernails and toenails. Bacteria which cause this type of infection are known as Candida. The infection begins as cellulitis but may progress to…- ベビー軟膏の世界市場（～2026年） Baby ointments are usually used to prevent diaper rash, dry skin, heat rash, eczema and insect bites. The skin of the babies and the adult differ in many respects. The skin of the babies is over sensitive and there is a tendency of flaking and peeling of the skin during the first three weeks just af…
- ベタメタゾン軟膏の世界市場（～2026年） Betamethasone ointment is a steroid medication that is used to treat a number of skin diseases such as dermatitis, allergic conditions, and itching. Market Analysis and Insights: Global Betamethasone Ointment Market The global Betamethasone Ointment market size is projected to reach US$ XX million b…
- 慢性疲労症候群治療の世界市場（～2026年） Chronic fatigue syndrome is not a simple problem for any individual, it’s a complex disorder which is considered as thrilling fatigue, which cannot be able to explain by medical conditions. Chronic fatigue syndrome which can prime to deterioration of creatively suffering and harm of quality of life,…
- 慢性骨髄性白血病治療の世界市場（～2026年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…